Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma

Eye (Basingstoke)

Volumn 28, Issue 6, 2014, Pages 662-671

  Kang, J H ^a   Loomis, S J ^b   Yaspan, B L ^c   Bailey, J C ^d   Weinreb, R N ^e   Lee, R K ^f   Lichter, P R ^g   Budenz, D L ^h   Liu, Y ⁱ   Realini, T ^j   Gaasterland, D ^k   Gaasterland, T ^e   Friedman, D S ^l   Mccarty, C A ^m   Moroi, S E ^g   Olson, L ^d   Schuman, J S ⁿ   Singh, K ^o   Vollrath, D ^o   Wollstein, G ⁿ   Zack, D J ^l   Brilliant, M ^p   Sit, A J ^q   Christen, W G ^a   Fingert, J ^r   Forman, J P ^a   Buys, E S ^s   Kraft, P ^t   Zhang, K ^e   Allingham, R R ⁱ   Pericak Vance, M A ^f   Richards, J E ^g   Hauser, M A ⁱ   Haines, J L ^d   Wiggs, J L ^b   Pasquale, L R ^a,b   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c GENENTECH INC   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j West Virginia University Eye Institute   (United States)

^k Eye Doctors of Washington   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

^m ESSENTIA INSTITUTE OF RURAL HEALTH   (United States)

ⁿ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^o STANFORD UNIVERSITY   (United States)

^p MARSHFIELD CLINIC   (United States)

^q MAYO CLINIC   (United States)

^r UNIVERSITY OF IOWA   (United States)

^s MASSACHUSETTS GENERAL HOSPITAL   (United States)

^t HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; CAV1 PROTEIN, HUMAN; CAVEOLIN 1; DNM2 PROTEIN, HUMAN; DYNAMIN; EDNRB PROTEIN, HUMAN; ENDOTHELIN RECEPTOR; GNB2 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ITPR3 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; PRKAA1 PROTEIN, HUMAN;

ARTICLE; BLOOD VESSEL TONE; COMPUTER PROGRAM; CONTROLLED STUDY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; SINGLE NUCLEOTIDE POLYMORPHISM; VISUAL FIELD; AGED; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; INTRAOCULAR PRESSURE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

AGED; AMP-ACTIVATED PROTEIN KINASES; CASE-CONTROL STUDIES; CAVEOLIN 1; DYNAMINS; ENDOTHELIUM, VASCULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLAUCOMA, OPEN-ANGLE; GTP-BINDING PROTEINS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION;

EID: 84902481879     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2014.42     Document Type: Article

References (73)

1. Leske MC. Open-angle glaucoma-an epidemiologic overview. Ophthal Epidemiol 2007; 14(4): 166-172.
2. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001; 20(3): 319-349.
3. Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 2001; 20(5): 595-624.
4. Hayreh SS, Revie IH, Edwards J. Vasogenic origin of visual field defects and optic nerve changes in glaucoma. Br J Ophthalmol 1970; 54(7): 461-472.
5. Von Graefe A. Uber die iridectomie bei glaukom und uber den glaucomatosen prozess. Von Graefe's Arch Ophthalmol 1857; 3: 456-555.
6. Moore D, Harris A, Wudunn D, Kheradiya N, Siesky B. Dysfunctional regulation of ocular blood flow: a risk factor for glaucoma? Clin Ophthalmol 2008; 2(4): 849-861
7. Schmidl D, Garhofer G, Schmetterer L. The complex interaction between ocular perfusion pressure and ocular blood flow-relevance for glaucoma. Exp Eye Res 2011; 93(2): 141-155.
8. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002; 21(4): 359-393.
9. Flammer J, Orgul S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res 1998; 17(2): 267-289.
10. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology 2008; 115(2): 246-252.
11. Feke GT, Hazin R, Grosskreutz CL, Pasquale LR. Effect of brimonidine on retinal blood flow autoregulation in primary open-angle glaucoma. J Ocular Pharmacol Therap 2011; 27(4): 347-352.
12. Su WW, Cheng ST, Ho WJ, Tsay PK, Wu SC, Chang SH. Glaucoma is associated with peripheral vascular endothelial dysfunction. Ophthalmology 2008; 115(7): 1173-1178 e1171.
13. Henry E, Newby DE, Webb DJ, O'Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci 1999; 40(8): 1710-1714.
14. Gasser P, Flammer J. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma. Am J Ophthalmol 1991; 111(5): 585-588.
15. Park HY, Jung KI, Na KS, Park SH, Park CK. Visual field characteristics in normal-tension glaucoma patients with autonomic dysfunction and abnormal peripheral microcirculation. Am J Ophthalmol 2012; 154(3): 466-475 e461.
16. Hitchings RA, Anderton SA. A comparative study of visual field defects seen in patients with low-tension glaucoma and chronic simple glaucoma. Br J Ophthalmol 1983; 67(12): 818-821.
17. Park SC, De Moraes CG, Teng CC, Tello C, Liebmann JM, Ritch R. Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics. Ophthalmology 2011; 118(9): 1782-1789.
18. Hulsman CA, Vingerling JR, Hofman A, Witteman JC, de Jong PT. Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam study. Arch Ophthalmol 2007; 125(6): 805-812.
19. Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000; 107(7): 1287-1293.
20. Cherecheanu AP, Garhofer G, Schmidl D, Werkmeister R, Schmetterer L. Ocular perfusion pressure and ocular blood flow in glaucoma. Curr Opin Pharmacol 2013; 13(1): 36-42.
21. Leske MC. Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings. Curr Opin Ophthalmol 2009; 20(2): 73-78.
22. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007; 114(11): 1965-1972.
23. Wiggs JL, Kang JH, Yaspan BL, Mirel DB, Laurie C, Crenshaw A et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum Mol Genet 2011; 20(23): 4707-4713.
24. Thorleifsson G, Walters GB, Hewitt AW, Masson G, Helgason A, DeWan A et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 2010; 42(10): 906-909.
25. Loomis SJ, Kang JH,Weinreb RN, Yaspan BL, Cooke Bailey JN, Gaasterland D et al. Association of CAV1/CAV2 genomic variants with primary open angle glaucoma overall and by gender and pattern of visual field loss. Ophthalmology 2014; 121(2): 508-516.
26. Yaspan BL, BushWS, Torstenson ES,MaD, Pericak-VanceMA, Ritchie MD et al. Genetic analysis of biological pathway data through genomic randomization. Hum Genet 2011; 129(5): 563-571.
27. Pasquale LR, Loomis SJ, Kang JH, Yaspan BL, Abdrabou W, Budenz DL et al. CDKN2B-AS1 genotype-glaucoma feature correlations in primary open-angle glaucoma patients from the United States. Am J Ophthalmol 2013; 155(2): 342-353 e345.
28. Wiggs J, Yaspan B, Hauser M, Kang J, Allingham R, Abdrabou W et al. Common variants in the CDKN2BAS region on 9p21 and a novel region on 8q23 are associated with the normal tension form of open-angle glaucoma with increased susceptibility to optic nerve degeneration. PLoS Genet 2012; 8(4): e1002654.
29. Lu Y, Vitart V, Burdon KP, Khor CC, Bykhovskaya Y, Mirshahi A et al. Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus. Nat Genet 2013; 45(2): 155-163.
30. Ulmer M, Li J, Yaspan BL, Ozel AB, Richards JE, Moroi SE et al. Genome-wide analysis of central corneal thickness in primary open-angle glaucoma cases in the NEIGHBOR and GLAUGEN consortia. Invest Ophthalmol Vis Sci 2012; 53(8): 4468-4474.
31. Ozel AB, Moroi SE, Reed DM, Nika M, Schmidt CM, Akbari S et al. Genome-wide association study and meta-analysis of intraocular pressure. Hum Genet 2013; 133(1): 41-57.
32. Wiggs J, Hauser M, Abdrabou W, Allingham R, Budenz D, DelBono E et al. The NEIGHBOR Consortium Primary Open Angle Glaucoma Genome-wide Association Study: rationale, study design and clinical variables. J Glaucoma 2012; 22(7): 517-525.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81(3): 559-575.
34. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics (Oxford, England) 2010; 26(17): 2190-2191.
35. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 2000; 28(1): 27-30.
36. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007; 35(Database issue): D521-D526.
37. Cooper GS, Miller FW, Pandey JP. The role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect 1999; 107(Suppl 5): 693-700.
38. Padmanabhan S, Newton-Cheh C, Dominiczak AF. Genetic basis of blood pressure and hypertension. Trends Genet 2012; 28(8): 397-408.
39. Pasquale LR, Loomis SJ, Weinreb RN, Kang JH, Yaspan BL, Bailey JC et al. Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States. Mol Vis 2013; 19: 1471-1481.
40. Venkataraman ST, Flanagan JG, Hudson C. Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma-a review. Microcirculation 2010; 17(7): 568-581.
41. Orgul S, Gugleta K, Flammer J. Physiology of perfusion as it relates to the optic nerve head. Surv Ophthalmol 1999; 43(Suppl 1): S17-S26.
42. Jandrasits K, Luksch A, Soregi G, Dorner GT, Polak K, Schmetterer L. Effect of noradrenaline on retinal blood flow in healthy subjects. Ophthalmology 2002; 109(2): 291-295.
43. Harris A, Ciulla TA, Chung HS, Martin B. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol 1998; 116(11): 1491-1495.
44. Schmetterer L, Polak K. Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res 2001; 20(6): 823-847.
45. Haefliger IO, Dettmann E, Liu R, Meyer P, Prunte C, Messerli J et al. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol 1999; 43: S51-S58.
46. Becquet F, Courtois Y, Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv Ophthalmol 1997; 42(1): 71-82.
47. Nathanson JA. Nitric oxide and nitrovasodilators in the eye: implications for ocular physiology and glaucoma. J Glaucoma 1993; 2(3): 206-210.
48. Wizemann AJ, Wizemann V. Organic nitrate therapy in glaucoma. Am J Ophthalmol 1980; 90(1): 106-109.
49. Nathanson JA, McKee M. Alterations of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci 1995; 36(9): 1774-1784.
50. Chuman H, Chuman T, Nao-i N, Sawada A. The effect of L-arginine on intraocular pressure in the human eye. Curr Eye Res 2000; 20(6): 511-516.
51. Behar-Cohen FF, Goureau O, D'Hermies F, Courtois Y. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci 1996; 37(8): 1711-1715.
52. Stamer WD, Lei Y, Boussommier-Calleja A, Overby DR, Ethier CR. eNOS, a pressure-dependent regulator of intraocular pressure. Invest Ophthalmol Vis Sci 2011; 52(13): 9438-9444.
53. Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol-Heart Circul Physiol 2003; 285(2): H631-H636.
54. Luksch A, Polak K, Beier C, Polska E, Wolzt M, Dorner GT et al. Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects. Invest Ophthalmol Vis Sci 2000; 41(10): 3080-3084.
55. Schmetterer L, Krejcy K, Kastner J, Wolzt M, Gouya G, Findl O et al. The effect of systemic nitric oxide synthase inhibition on ocular fundus pulsations in man. Exp Eye Res 1997; 64(3): 305-312.
56. Resch H, Garhofer G, Fuchsjager-Mayrl G, Hommer A, Schmetterer L. Endothelial dysfunction in glaucoma. Acta Ophthalmol 2009; 87(1): 4-12.
57. Hashizume K, Mashima Y, Fumayama T, Ohtake Y, Kimura I, Yoshida K et al. Genetic polymorphisms in the angiotensin II receptor gene and their association with open-angle glaucoma in a Japanese population. Invest Ophthalmol Vis Sci 2005; 46(6): 1993-2001.
58. Bunce C, Hitchings RA, Van Duijn CM, De Jong P, Vingerling JR. Associations between the deletion polymorphism of the angiotensin 1-converting enzyme gene and ocular signs of primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2005; 243(4): 294-299.
59. Ozkur M, Erbagci B, Gungor K, Nacak M, Aynacioglu S, Bekir NA. Angiotensin-converting enzyme insertion-deletion polymorphism in primary open-angle glaucoma. Ophthalmologica 2004; 218(6): 415-418.
60. Inagaki Y, Mashima Y, Fuse N, Funayama T, Ohtake Y, Yasuda N et al. Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma. Mol Vis 2006; 12(73-75): 673-680.
61. Gungor K, Ozkur M, Cascorbi I, Brockmoller J, Bekir N, Roots I et al. Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucoma. Eur J Clin Pharmacol 2003; 59(7): 527-531.
62. Ayub H, Khan MI,Micheal S, Akhtar F, AjmalM, Shafique S et al. Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts. Mol Vis 2010; 16(2-3): 18-25.
63. da Silva TM, Rocha AV, Lacchini R, Marques CR, Silva ES, Tanus-Santos JE et al. Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population. Gene 2012; 502(2): 142-146.
64. Kang JH, Wiggs JL, Rosner BA, Hankinson SE, Abdrabou W, Fan BJ et al. The relation between endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with gender and postmenopausal hormone use. Invest Ophthalmol Vis Sci 2010; 51: 971-979.
65. Liao QO, Wang DH, Sun HJ. Association of genetic polymorphisms of eNOS with glaucoma. Mol Vis 2011; 17(17-20): 153-158.
66. Logan JF, Chakravarthy U, Hughes AE, Patterson CC, Jackson JA, Rankin SJ. Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and a history of migraine. Invest Ophthalmol Vis Sci 2005; 46(9): 3221-3226.
67. Tunny TJ, Richardson KA, Clark CV. Association study of the 50 flanking regions of endothelial-nitric oxide synthase and endothelin-1 genes in familial primary open-angle glaucoma. Clin Exp Pharmacol Physiol 1998; 25(1): 26-29.
68. Weiss J, Frankl SA, Flammer J, Grieshaber MC, Hollo G, Teuchner B et al. No difference in genotype frequencies of polymorphisms of the nitric oxide pathway between Caucasian normal and high tension glaucoma patients. Mol Vis 2012; 18(229-31): 2174-2181.
69. Fan BJ, Liu K,Wang DY, Tham CCY, Tam POS, Lam DSC et al. Association of polymorphisms of tumor necrosis factor and tumor protein p53 with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2010; 51(8): 4110-4116.
70. Rath G, Dessy C, Feron O. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation. J Physiol Pharmacol 2009; 60(Suppl 4): 105-109.
71. Wu C, Orozco C, Boyer J, LegliseM, Goodale J, Batalov S et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009; 10(11): R130.
72. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D et al. A gene atlas of the mouse and human proteinencoding transcriptomes. Proc Natl Acad Sci USA 2004; 101(16): 6062-6067.
73. Wang SY, Singh K, Lin SC. The association between glaucoma prevalence and supplementation with the oxidants calcium and iron. Invest Ophthalmol Vis Sci 2012; 53(2): 725-731.